# Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Study · id `cardio:ct-nct04014803` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04014803](<https://clinicaltrials.gov/study/NCT04014803>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04014803

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3500 participants.

## Technical summary

Registry record NCT04014803. Randomized; no masking; primary purpose treatment. Start 2020-01-13 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3500 participants (planned count; ClinicalTrials.gov record NCT04014803, source copy `cardio:ctgov-nct04014803-2026-02-09`, retrieved 2026-10-26)
- Started: 2020-01-13 (actual) (ClinicalTrials.gov record NCT04014803, source copy `cardio:ctgov-nct04014803-2026-02-09`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT04014803, source copy `cardio:ctgov-nct04014803-2026-02-09`, retrieved 2026-10-26)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT04014803, source copy `cardio:ctgov-nct04014803-2026-02-09`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04014803, source copy `cardio:ctgov-nct04014803-2026-02-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04014803-2026-02-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
- Acronym: ATTEMPT
- Condition: Coronary Artery Disease
- Intervention (Drug): Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin
- Lead sponsor: Samsung Medical Center
- Lead sponsor class: OTHER
- Collaborator: Inje University Ilsan Paik Hospital
- Collaborator class: OTHER
- Collaborator: Seoul St. Mary's Hospital
- Collaborator class: OTHER
- Collaborator: Mediplex Sejong Hospital
- Collaborator class: UNKNOWN
- Collaborator: Chonnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Sejong General Hospital
- Collaborator class: OTHER
- Collaborator: Wonkwang University Hospital
- Collaborator class: OTHER
- Collaborator: Gachon University Gil Medical Center
- Collaborator class: OTHER
- Collaborator: Keimyung University Dongsan Medical Center
- Collaborator class: OTHER
- Collaborator: Chungbuk National University Hospital
- Collaborator class: OTHER
- Collaborator: Yeungnam University Hospital
- Collaborator class: OTHER
- Collaborator: Chungnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Wonju Severance Christian Hospital
- Collaborator class: OTHER
- Collaborator: Konkuk University Chungju Hospital
- Collaborator class: UNKNOWN
- Collaborator: Chung-Ang University Hospital
- Collaborator class: OTHER
- Collaborator: Dankook University
- Collaborator class: OTHER
- Collaborator: Incheon St.Mary's Hospital
- Collaborator class: OTHER
- Collaborator: Gyeongsang National University Hospital
- Collaborator class: OTHER
- Collaborator: Soonchunhyang University Hospital
- Collaborator class: OTHER
- Collaborator: Ewha Womans University Seoul Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 17 registry organizations

## Provenance

Content hash: 03dcfb67e5ee9b922526ab3124d262c9288d563fd6b425a6e08ff95e172ba69f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
